BridgeMD
New treatment option for Hepatitis C
Official title Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
ClinicalTrials.gov ID: NCT06159504
What this study is testing
What is sofosbuvir/velpatasvir (SOF/VEL)?
sofosbuvir/velpatasvir (SOF/VEL) is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for hepatitis c.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this non-randomised, quasi-experimental, prospective comparative trial is to trial simplified care pathways for hepatitis C testing and treatment for people who inject drugs in Armenia, Georgia, and Tanzania. The main questions it aims to answer are: 1.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years or older
- Able and willing to provide informed consent in local language
- Not currently on or previously had treatment for hepatitis C
- Attending site for needle / syringe program, OR self-reports ever injecting drugs
You likely can't join if
- Self-reported history of decompensate cirrhosis of the liver
- Women who are pregnant or breast-feeding
- Self-report other significant co-morbidities such as uncontrolled HIV infection, history of renal dysfunction, tuberculosis infection, or chronic...
- Unable / unwilling to stop any contraindicated medications / supplements
The study team makes the final eligibility decision.
Where it's taking place
- Yerevan, Armenia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yerevan, Armenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.